← Eichor
Condition: Immune Development Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Immune Development

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions
Phase N/A · 1 location(s) · Children's National Research Institute · NCT04833465Exploring the Cutaneous Immune Response to Skin Massage in Early Life
NA · 1 location(s) · King's College London · NCT07228728Sample Collection and Tracking for the Developmental Therapeutics Clinic
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT03269578Experience of Biologic Treatments for Severe Asthma: a Survey
Phase N/A · 1 location(s) · Royal Devon and Exeter NHS Foundation Trust · NCT06903780Fall Prevention Among People With Spinal Cord Injury and Multiple Sclerosis Who Use Wheelchairs and Scooters
NA · 1 location(s) · University of Illinois at Urbana-Champaign · NCT07167680Hirschsprung's Advances; Working Towards Autologous tIssue therapIes
Phase N/A · 1 location(s) · Alder Hey Children's NHS Foundation Trust · NCT06590142A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Part
Phase 1 · 42 location(s) · Regeneron Pharmaceuticals · NCT05137054Twins Born in Guangzhou
Phase N/A · 1 location(s) · Guangzhou Women and Children's Medical Center · NCT03331133A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells.
Phase N/A · 1 location(s) · BioCytics, Inc. · NCT00571389Phase IIa Trial in Participants With Asthma to Evaluate Impact of Intranasal ETH47 on Development of Asthma-related Symp
Phase 2 · 2 location(s) · Ethris GmbH · NCT07059767To Investigate the Effects of Bifidobacterium Animalis Subsp. Lactis XLTG11 on Growth and Development, Incidence of Alle
Phase 2 · 2 location(s) · Min-Tze LIONG · NCT07490587Thai PainPREDICT Validation Study
NA · 1 location(s) · Chulalongkorn University · NCT07195045Biomarker Development for Autoimmune Disorders Involving the Kidneys
Phase N/A · 1 location(s) · Oslo University Hospital · NCT07666711Development of Camera Based Gait Quality Measure for Persons With Multiple Sclerosis
Phase N/A · 1 location(s) · Shirley Ryan AbilityLab · NCT06516458The DC Cohort Longitudinal HIV Status Neutral Study
Phase N/A · 14 location(s) · George Washington University · NCT01206920Impact of In Utero Exposure to Immunomodulatory Drugs on Neonatal Immune System Development
Phase N/A · 3 location(s) · Fundació Sant Joan de Déu · NCT07033663Proteomic Biomarker Tests in Blood Samples from Children with Autism Spectrum Disorder (ASD)
Phase N/A · 1 location(s) · Benjamin Gesundheit · NCT02168868Plan Development for Giving Teclistamab in the Outpatient Setting
Phase 4 · 1 location(s) · University Health Network, Toronto · NCT06251076Efficacy and Biomarker Development for Lung Cancer Treated With Immune Checkpoint Inhibitors
Phase 3 · 1 location(s) · Hunan Province Tumor Hospital · NCT05055908AutoInflammatory Disease Alliance Registry (AIDA)
Phase N/A · 112 location(s) · University of Siena · NCT05200715Lynch Syndrome X-Talk of Enteral Mucosa With Immune System
Phase N/A · 5 location(s) · San Raffaele University · NCT06708429EmoTIChealth: Promoting Adolescent Health Through a Serious Game.
NA · 1 location(s) · University of Valencia · NCT07212530Liquid Biopsy Evaluation and Repository Development at Princess Margaret
Phase N/A · 1 location(s) · University Health Network, Toronto · NCT03702309PANDA Gym: Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability
Phase N/A · 1 location(s) · University of Pennsylvania · NCT04321200A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With
Phase 3 · 109 location(s) · Janssen Research & Development, LLC · NCT07258511A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Disease
Phase 1 · 13 location(s) · Arcellx, Inc. · NCT06626919The Role of Biomarkers in the Occurrence and Development of Asthma
Phase N/A · 1 location(s) · Children's Hospital of Chongqing Medical University · NCT05768399Interventions in Mathematics and Cognitive Skills
NA · 1 location(s) · Stanford University · NCT05201534Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry (TSC-LAM Registry)
Phase N/A · 1 location(s) · David M. Ritter · NCT06160310A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regi
Phase 3 · 138 location(s) · AstraZeneca · NCT07391657
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.